Novartis: Uveitis trials

The registry lists 11 Uveitis studies with Novartis as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 2 3Phase 3 7No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy of AIN457 in Patients With Active Non-infectious UveitisTerminatedNCT01095250Phase 3Results posted
• 38 Week Extension Study to CAIN457C2303TerminatedNCT01093846Phase 3Results posted
• Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious UveitisTerminatedNCT01090310Phase 3Results posted
• Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious UveitisTerminatedNCT01032915Phase 3Results posted
• Phase III Study in Refractory Behcet's DiseaseCompletedNCT00995709Phase 3Results posted
• Safety and Efficacy of AIN457 in Noninfectious UveitisCompletedNCT00685399Phase 2Results posted
• Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular OcclusionCompletedNCT05657158
• Study of FTY720 in Patients With UveitisWithdrawnNCT01791192Phase 2
• Study to Evaluate the Long Term Use of Treatment With AIN457 for UveitisWithdrawnNCT01327664Phase 3
• Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious UveitisWithdrawnNCT01103024Phase 3
• Safety, Tolerability, and Efficacy of AEB071 in the Treatment of UveitisCompletedNCT00615693Phase 2